NY A 5330
in committeeRelates to establishing a uterine fibroids awareness and education program
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 5330 pass?
Not yet. NY A 5330 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH
What is NY A 5330 about?
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Who sponsors NY A 5330?
Jessica Gonzalez-Rojas is the primary sponsor of NY A 5330, joined by 9 cosponsors.
Description
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Jessica Gonzalez-Rojasprimary
- Jo Anne Simoncosponsor
- Al Taylorcosponsor
- Eddie Gibbscosponsor
- Christopher Eachuscosponsor
- Latrice Walkercosponsor
- Phara Souffrant Forrestcosponsor
- MaryJane Shimskycosponsor
- Rodneyse Bichotte Hermelyncosponsor
- Karines Reyescosponsor
Committees
Not provided by source.
Action timeline
2025-02-13
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- A5330Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: A 9446not in this corpus
- Prior session: A 10048not in this corpus
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 5330. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.